Typically, manuals of pediatric hematology-oncology are written by specialists from high-income countries, and usually target an audience with a sub-specialist level of training, often assisted by cutting-edge diagnostic and treatment facilities. However, approximately 80% of new cases of cancer in children appear in mid- and low-income countries. Almost invariably, general practitioners or general pediatricians without special training in oncology will look after children with malignancies who enter the health care system in these countries. The diagnostic facilities are usually limited, as are the treatment options. The survival figures in these conditions are somewhere below 20%, while in high-income countries they are in the range of 80% for many childhood cancers. Pediatric Hematology-Oncology in Countries with Limited Resources is the only book of its kind to provide specific guidance applicable to limited resource settings and builds up from the foundation of general practitioner or general pediatrician competence. Written and edited by leaders in the field, this manual educates physicians on the essential components of the discipline, filtered through the experience of specialists from developing countries, with immediate applicability in the specific healthcare environment in these countries.​

In Treatment of Acute Leukemias, international experts not only review the state-of-the-art in managing children and adults with acute leukemia, but also debate the pros and cons of current controversial and problematic issues. The book summarizes the best diagnostic and treatment practices for acute leukemias in children, adolescents, and adults. Among the therapies discussed are methotrexate, asparaginase, antipurines, epipodophyllotoxins, hematopoietic stem cell transplantation, hematopoietic growth factors, and immunotherapy.

A new, definitive, state-of-the-art reference in the specialist field of paediatric surgical oncology. Key points and informative guidance on all aspects of cancer surgery for children make this a vital textbook for the surgery resident, surgical oncology specialist, nursing staff and cancer health care teams. The editorial team of world experts and international guest authorship listings guarantees that the textbook content provides a definitive treatise for a global audience of pediatric surgeons. Textbook coverage includes chapters on pediatric cancer epidemiology, chemotherapy, immunotherapy, radiotherapy, pathology, radiology and vascular access, following which the main theme sections feature all of the major pediatric solid tumours in a system-based chronology. A section devoted to rare tumours provides useful and pragmatic information for the oncology surgeon. Minimally invasive surgery is covered highlighting current concepts and clinical outcome(s) by leading experts in the field. Nutritional considerations for the pediatric cancer patient undergoing surgery are all discussed. Management of surgical complications, fertility considerations and long-term outcomes are an invaluable vital resource for the reader. Final sections "look to the future" by focusing on surgical innovation, including key chapters on navigational surgery and surgical robotics. • Includes all the latest developments in pediatric surgical oncology ensuring the reader is kept fully up to date. • Multi-disciplinary content reflects current best practice. • Comprehensive coverage provides a definitive reference guide. An authoritative seminal reference work for surgical residents in training, surgeons working in the field of pediatric oncology, medical oncologists, intensive care specialists, nursing staff and allied health care professionals.

For many people in both developing and developed countries universal healthcare is still not the norm. Socio-economic status and geographical restrictions have proved to be major barriers to accessible care. The use of information and communication technologies ICT is growing rapidly internationally as the need to provide more efficient and cost-effective care becomes increasingly urgent. Improving the health of a nation begins with the individual and recent developments in genomics and mobile networked information technologies have regenerated interest in individualizing healthcare. Harnessing the diversity and ubiquity of

This text is the only book of its kind to provide specific guidance applicable to limited resource settings and builds up from the foundation of general practitioner or general pediatrician competence. Written and edited by leaders in the field, this manual educates physicians on the essential components of the discipline, filtered through the experience of specialists from developing countries, with immediate applicability in the specific healthcare environment in these countries. Typically, manuals of pediatric hematology-oncology are written by specialists from high-income countries, and usually target an audience with a sub-specialist level of training, often assisted by cutting-edge diagnostic and treatment facilities. However, approximately 80% of new cases of cancer in children appear in mid- and low-income countries. Almost invariably, general practitioners or general pediatricians without special training in oncology will look after children with malignancies who enter the health care system in these countries. The diagnostic facilities are usually limited, as are the treatment options. The survival figures in these conditions are somewhere below 20%, while in high-income countries they are in the range of 80% for many childhood cancers. This book includes simplified therapy protocols, pain therapy and palliation, as well as ward procedures such as bone marrow aspiration/biopsies, intravenous therapy and chemotherapy drugs mixing. It provides an overview of pediatric cancer epidemiology, cancer registration and organizing support networks and features the management of cancers with associated pathology like AIDS, malnutrition, malaria and tuberculosis.

The book contains the information of various aspects of newer developments and recent advances in the field of central nervous system (CNS) tumor molecular biology, tumor progression, clinical presentation, imaging and management. The authors from different reputed institutions shared their knowledge on this open access platform to disseminate their knowledge at global level. As it is obvious in the current text, the field of neurooncology is heterogeneous and under continuous development with addition of new knowledge and information on regular basis. The collective contributions from experts attempt to provide updates regarding ongoing research and developments pertaining to CNS tumor genetics and molecular aspects and their applied aspect in reference to patient management.